MicroStrategy Expands Private Offering of Convertible Notes to $2.6 Billion

Share This Post

Michael Saylor Bitcoin strategy

The post MicroStrategy Expands Private Offering of Convertible Notes to $2.6 Billion appeared first on Coinpedia Fintech News

In the latest development, MicroStrategy has disclosed that it has upsized and priced its previously announced private offering of convertible senior notes. Initially set at $1.75 billion, the offering has now been increased to $2.6 billion in 0% convertible senior notes due in 2029. Additionally, the company has granted initial purchasers an option to buy up to $400 million more in notes within three days of issuance. The offering is expected to close on November 21, 2024, subject to satisfaction of customary closing conditions.

The company, which purchased $4.6 billion worth of BTC last week, plans to use a major portion of the funds from the new bond issuance to buy more BTC. Notably, this news has further fortified Bitcoin, potentially breaching the 100,000 level in the upcoming days. 

Notably, the $2.6 billion offer is meant for qualified institutional buyers and is expected to close on November 21, 2024, with net proceeds estimated at approximately $2.58 billion, or $2.97 billion if the option for additional notes is exercised in full. MicroStrategy plans to use the proceeds to purchase more Bitcoin and for general corporate purposes.

MicroStrategy’s Latest Achievements

MicroStrategy Incorporated has been making significant strides in its Bitcoin investment strategy. It recently acquired an additional 51,780 Bitcoins, funded by a stock offering that generated around $4.6 billion, increasing its total Bitcoin holdings to approximately 331,200. 

The firm also entered the top 100 U.S. publicly traded companies, which is currently in the 97th place. The milestone follows an impressive 12% surge in its stock price, closing Tuesday at $430 per share after it crossed the $400 mark earlier in the day. Notably, its exceptional performance overlapped with Bitcoin hitting new all-time highs of over $94,000. 

The cryptocurrency market remains dynamic today as Bitcoin trades steadily at $94,690, up over 2% in the last 24 hours. Analysts expect bitcoin to reach $100,000 before the end of the month. Positive Bitcoin ETF inflows are also supporting the rally. On Nov. 19, the US spot Bitcoin ETFs recorded over $816 million worth of cumulative net inflows.

Read Entire Article
spot_img
- Advertisement -spot_img

Related Posts

$4,000 Solana Price Possible As SOL Breaks Out Of Massive Cup And Handle Pattern

The Solana price could be gearing up to reach a new ATH of $4,000, according to an analyst who highlighted its recent breakout from a massive Cup and Handle pattern This bullish signal comes on the

Former FTX CTO Gary Wang Spared Prison Time For Cooperating With Prosecutors

The post Former FTX CTO Gary Wang Spared Prison Time For Cooperating With Prosecutors appeared first on Coinpedia Fintech News Former FTX chief technology officer and close friend of Sam

BIS report on DeFi activity reveals institutional traders heavily outmaneuver retail on Uniswap

The Bank for International Settlements (BIS) has revealed that institutional players dominate liquidity provision on decentralized exchanges (DEXs) like Uniswap, according to a Nov 19 report, In a

Gen Z Trader’s $30K Heist Backfires as Crypto Community Rallies Token to $56M Market Cap

A young trader pulled off a pump-and-dump scheme on the coin called QUANT token, but the crypto community countered by rallying the token’s price Trader Live Streams Token Dump A pump-and-dump

Dogecoin Fibonacci Spiral Puts Price As High As $4.2 As It Enters 3rd Iteration

Crypto analyst Tmilnebml has highlighted a bullish pattern that is forming on the Dogecoin price chart Based on this, the analyst predicted that the DOGE price could rally to as high as $42 as the

Biotechs Going Big On BTC; Hoth Therapeutics To Buy $1 Million In Bitcoin

The post Biotechs Going Big On BTC; Hoth Therapeutics To Buy $1 Million In Bitcoin appeared first on Coinpedia Fintech News In a remarkable development, biopharmaceutical companies have revealed